echo does not require parentheses.Member Portal


TORONTO, ON – March 23, 2023 — Life Sciences Ontario is pleased to welcome Brigitte Nolet, President and CEO of Roche Canada Pharma, and Carrie McElroy, Canadian Head of Market Access & Public Affairs at Sanofi, onboard as board members. It is indeed exciting to have these talented and accomplished women join our leadership team.

“LSO is thrilled to welcome these phenomenal leaders to our board of directors,” says Dr. Jason Field, President and CEO of Life Sciences Ontario. “We are committed to building an inclusive board, and we are certain that their diverse backgrounds and expertise will be invaluable as we work to achieve our goals and drive the life sciences sector forward.”


As President and CEO of Roche Canada Pharma, Brigitte Nolet is responsible for the growth and success of the Canadian Pharmaceuticals Division, as it aligns to the company’s goals of providing novel healthcare solutions to Canadians. She leads a diverse team of nearly 2,000 employees from Roche’s Canadian Pharmaceutical headquarters in Mississauga, Ontario

Currently, Brigitte is a board member of BIOTECanada as well as Innovative Medicines Canada (IMC), and is CEO sponsor of the IMC Quebec committee. She is also a member of the Healthcare Businesswomen’s Association’s partner advisory board.

Before joining Roche, Brigitte was Vice President of Federal Government Affairs and Federal/Provincial/Territorial Issues for Canada’s Research-Based Pharmaceutical Companies (Rx&D). A native of Welland, Ontario, Canada, Brigitte holds a degree in English Rhetoric and Professional Writing, a degree in Social Development Studies from the School of Social Work, and a minor in Women’s Studies from the University of Waterloo.

With Brigitte Nolet’s wealth of experience and expertise in the pharmaceutical and life sciences sector, on a local and international level, she will undoubtedly bring valuable insights and unique perspectives to the table.


Carrie McElroy is the Canadian Head of Market Access & Public Affairs at Sanofi. With 22 years at Sanofi, Carrie has contributed to the organization across many leadership roles with a specialty in external affairs and as interim General Manager and Country Lead for a period in 2021.

Sanofi Canada is the leading investor in the Life Sciences sector in Canada which has afforded Carrie the opportunity to collaborate on capital investments, health system reform, policy priorities, and as a speaker and contributor in the life sciences ecosystem.

In addition to Carrie’s extensive corporate experience, she remains a tireless advocate for patients having served on many councils and committees in the non-profit sector. Carrie previously founded ‘Project Sarah’ – a Childhood Cancer Foundation after dear family friends lost their 3-year-old daughter to Neuroblastoma. In 2011, Carrie accompanied patients living with Rare Diseases on a successful trek to the Arctic Circle. This endeavor led to public awareness of Rare Conditions and created a dialogue with the Federal Government to create a Canadian Rare Disease Strategy.

Join us in welcoming Brigitte Nolet and Carrie McElroy to LSO’s board of directors. We wish them and the entire board all the best as they work together to advance our organization’s mission and goals for life sciences in Ontario.